Previous 10 | Next 10 |
Gainers: Biofrontera (NASDAQ:BFRI) +29%, Terns Pharmaceuticals (NASDAQ:TERN) +20%, Aurinia Pharmaceuticals (NASDAQ:AUPH) +17%, Atreca (NASDAQ:BCEL) +12%, 4D pharma (NASDAQ:LBPS) +9%. Losers: Context Therapeutics (NASDAQ:CNTX) -29%, 180 Life Sc...
The recent volatility on Wall Street continued during Wednesday's session, as fears about the Omicron variant continued to weigh on sentiment. Travel stocks felt the brunt of this concern, with United Airlines (NASDAQ:UAL), Delta Air Lines (NYSE:DAL), Carnival (NYSE:CCL), Alaska Air Group (NY...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Arbutus Biopharma (NASDAQ: ABUS ) stock is taking off on Wednesday thanks to a court ruling in its favor in a case against Moderna (NASDAQ: MRNA ). Source: Shutterstock The good news for Arbutus Biopharm...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Box (NYSE: BOX ) stock is on the rise Wednesday and it’s thanks to the company’s earnings report for the third quarter of fiscal 2022. Source: Sundry Photography / Shutterstock.com The positive n...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips IQIYI (NASDAQ: IQ ) stock is on the move Wednesday following reports that the company is cutting a huge amount of its workforce in layoffs. Source: NYC Russ / Shutterstock.com Let’s dive into that repor...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips December is off to a complicated start for the biotech sector so far. While VBI Vaccines (NASDAQ: VBIV ) has garnered Food and Drug Administration (FDA) approval for a vaccine designed to prevent Hepatitis B, one of...
Gainers: Arbutus Biopharma (NASDAQ:ABUS) +87%. MDJM (NASDAQ:MDJH) +41%. Context Therapeutics (NASDAQ:CNTX) +35%. Build-A-Bear Workshop (NYSE:BBW) +33%. Ardelyx (NASDAQ:ARDX) +28%. Ambarella (NASDAQ:AMBA) +25%. Roivant Sciences (NASDAQ:ROIV) +22%. Stran & Company (NASDAQ:STRN) +20%. Marpai...
Gainers: Arbutus Biopharma (NASDAQ:ABUS) +47%. Ardelyx (NASDAQ:ARDX) +31%. Context Therapeutics (NASDAQ:CNTX) +19%. ImmunoGen (NASDAQ:IMGN) +17%. Skylight Health Group (NASDAQ:SLHG) +16%. Losers: BeyondSpring (NASDAQ:BYSI) -53%. Aditxt (NASDAQ:ADTX) -25%. CTI (NASDAQ:CTIC)...
BeyondSpring Pharmaceuticals (NASDAQ:BYSI) announced that the FDA has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) seeking the approval of a combination regimen containing plinabulin for chemotherapy-induced neutropenia (CIN). The company had sought regulatory ap...
NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced it has received a Complete Response Lette...
News, Short Squeeze, Breakout and More Instantly...
COPT Defense Properties of Beneficial Interest (CDP) is expected to report $0.64 for Q2 2024 Bank of Marin Bancorp (BMRC) is expected to report $0.19 for Q2 2024 Oak Ridge Financial Services Inc (BKOR) is expected to report for Q2 2024 D/B/A Centerspace (CSR) is expected to report $1....
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...
FLORHAM PARK, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it hosted a virtua...